Hip Fracture SurgeriesPhase 4NCT07613801
FASCIA ILIACA BLOCK VERSUS INTRAVENOUS NALBUPHINE AS ANALGESIC METHOD BEFORE POSITIONING FOR SPINAL ANESTHESIA IN PATIENTS UNDERGOING SURGERY FOR HIP FRACTURES
A Phase 4 study testing Bupivacain and Nalbuphine in people with Hip Fracture Surgeries, run by Liaquat National Hospital & Medical College at 1 site in Pakistan.
Trial summary
Investigators will compare FASCIA ILIACA BLOCK VERSUS INTRAVENOUS NALBUPHINE AS ANALGESIC METHOD BEFORE POSITIONING FOR SPINAL ANESTHESIA IN PATIENTS UNDERGOING SURGERY FOR HIP FRACTURES Read more about this study
- Who is it for?
- Ages 30 years and olderHealthy volunteers can take part
- Conditions the study is for
- Hip Fracture Surgeries
- What is being tested?
- Bupivacain and Nalbuphine
- Could I receive a placebo?
- No, everyone receives an active treatment
- How many people
- 30 participants
- Where
- 1 sitePakistan
- Study dates
- 12 May 2026to 12 Nov 2026
- Phase
- Phase 4
- Are there results?
- Not yet: the study is under way
Key requirements
Who can take part, as listed by the sponsor. Only the study team can confirm whether you are eligible, so take this list to your doctor.
- Ages 30 years and older
- All sexes
- Healthy volunteers accepted
- Adult, Older adult
Who may be able to join
- Age above 30 years
Who cannot join
- Age before 30
Trial locations and contacts
1 site in 1 country.
About this study
Investigators will compare FASCIA ILIACA BLOCK VERSUS INTRAVENOUS NALBUPHINE AS ANALGESIC METHOD BEFORE POSITIONING FOR SPINAL ANESTHESIA IN PATIENTS UNDERGOING SURGERY FOR HIP FRACTURES
- Conditions
- Hip Fracture Surgeries
- Being tested
- Bupivacain, Nalbuphine
What participants receive
What participants receive. In a randomised study each person is assigned to one group by chance.
BupivacainDrug
We will compare fascia ILIACA block with nalbuphine
NalbuphineDrug
We will compare this with fascia ilaca block
| Study group | Role | What they receive |
|---|---|---|
| Fascia ILIACA block | Active comparator | We will compare this with nalbuphine Receives: Drug: Bupivacain |
| Nalbuphine | Active comparator | We will compare this with fascia ILIACA block Receives: Drug: Nalbuphine |
What is being measured
The primary outcome is the main question the study is designed to answer.
Pain score(VAS score) after 15 minutes of either intervention before spinal anesthesia
Measured: 15 minutes
Quality of positioning for spinal anesthesia after 15 minutes of either intervention
Scale of 0-3 for hip flexion while sitting after either intervention 0=not satisfactory (poor hip flexion)
- satisfactory (slight hip flexion)
- good (adequate hip flexion)
- optimal (excellent hip flexion)
Measured: 15 minutes
Secondary outcomes (3)
Assessment of heart rate
Measured in beat per minute
Measured: 15 minutes
Assessment of blood pressure
Measured in mmHg
Measured: 15 minutes
Comfort of patient
Objective observational pain indicators reflecting the patient's acceptance and and tolerance of positioning.
0=calm
- facial grimacing
- moaning
- screaming
- unable to proceed due to agitation or restlessness
Measured: 15 minutes
Timeline
From the start of the study to its completion; the mark is today. Estimated dates are the sponsor’s plan.
- First posted29 May 2026
- Study start12 May 2026
- Primary completion12 Nov 2026 (estimated)
- Study completion12 Nov 2026 (estimated)
Resources
- Official record on ClinicalTrials.govThe registry entry this page is built from, with its full change history.
- Other trials for Hip Fracture SurgeriesStudies of the same condition, open and under way.
- What the trial phases meanHow a treatment moves from first tests in people to approval.
More details
For doctors and researchers: how the study is designed, who runs it, and its registry IDs.
Study design
- Study type
- Interventional
- Phase
- Phase 4
- Primary purpose
- Treatment
- Allocation
- Randomised
- Intervention model
- Parallel groups
- Masking
- None (open label)
- Enrolment
- 30 participants (estimated)
Sponsor and investigators
- Lead sponsor
- Liaquat National Hospital & Medical College
- Sponsor type
- University, hospital or other
- Responsible party
- Principal investigator, Yumna saeed, Liaquat National Hospital & Medical College
IDs, dates and publications
- ClinicalTrials.gov ID
- NCT07613801
- Sponsor's protocol ID
- LNHMC
- Status last verified
- May 2026
- First submitted
- 14 May 2026
- Last updated
- 29 May 2026
- Results posted
- No
- Data monitoring committee
- No
- FDA-regulated drug
- Yes
- FDA-regulated device
- No
- Individual data sharing
- No
Study at a glance
From the registry record, last updated by the sponsor on 29 May 2026. Recruitment status is as the sponsor reported it: confirm with the study team.
- Official title
- FASCIA ILIACA BLOCK VERSUS INTRAVENOUS NALBUPHINE AS ANALGESIC METHOD BEFORE POSITIONING FOR SPINAL ANESTHESIA IN PATIENTS UNDERGOING SURGERY FOR HIP FRACTURES
- ClinicalTrials.gov ID
- NCT07613801
- Acronym / sponsor ID
- LNHMC
- Conditions
- Hip Fracture Surgeries
- Phase
- Phase 4
- Study type
- Interventional
- Recruitment status
- Active, not recruiting
- Enrolment
- 30 participants (estimated)
- Lead sponsor
- Liaquat National Hospital & Medical CollegeUniversity, hospital or other
- Study start
- 12 May 2026 (actual)
- Primary completion
- 12 Nov 2026 (estimated)
- Study completion
- 12 Nov 2026 (estimated)
- First posted
- 29 May 2026 (actual)
- Results
- Not posted in the source record
Clinical summary
The research question as the sponsor registered it. This describes what the study plans to test, not what it found.
Investigators will compare FASCIA ILIACA BLOCK VERSUS INTRAVENOUS NALBUPHINE AS ANALGESIC METHOD BEFORE POSITIONING FOR SPINAL ANESTHESIA IN PATIENTS UNDERGOING SURGERY FOR HIP FRACTURES
Study design
- Primary purpose
- Treatment
- Allocation
- Randomised
- Intervention model
- Parallel groups
- Masking
- None (open label)
- Number of arms
- 2
| Arm | Type | Receives |
|---|---|---|
| Fascia ILIACA block | Active comparator | Drug: BupivacainWe will compare this with nalbuphine |
| Nalbuphine | Active comparator | Drug: NalbuphineWe will compare this with fascia ILIACA block |
Who may qualify
- Ages
- 30 years and older
- Sex
- All
- Healthy volunteers
- Accepted
- Age groups
- Adult, Older adult
Key inclusion criteria (1 listed)
- Age above 30 years
Key exclusion criteria (1 listed)
- Age before 30
Eligibility is decided by the study team after screening; this overview does not establish that a patient qualifies. Full inclusion and exclusion criteria.
Interventions
| Intervention | Type | Arms |
|---|---|---|
| BupivacainWe will compare fascia ILIACA block with nalbuphine | Drug | Fascia ILIACA block |
| NalbuphineWe will compare this with fascia ilaca block | Drug | Nalbuphine |
Primary outcome
Pain score(VAS score) after 15 minutes of either intervention before spinal anesthesia
Time frame: 15 minutes
Quality of positioning for spinal anesthesia after 15 minutes of either intervention
Time frame: 15 minutes
Scale of 0-3 for hip flexion while sitting after either intervention 0=not satisfactory (poor hip flexion) 1. satisfactory (slight hip flexion) 2. good (adequate hip flexion) 3. optimal (excellent hip flexion)
3 secondary outcomes
Assessment of heart rate
Time frame: 15 minutes
Assessment of blood pressure
Time frame: 15 minutes
Comfort of patient
Time frame: 15 minutes
Results and safety
This study is still under way. Results are not available in the source record yet.
Research links
- Official record on ClinicalTrials.govLast updated by the sponsor 29 May 2026.
- Individual participant dataSharing planned: No
Related trials for Hip Fracture Surgeries
Not yet recruitingPhase 4
Effect of Ondansetron on the Incidence of Spinal Anaesthesia-Induced Hypotension in Elderly Patients Undergoing Fracture Hip Surgery
Spinal Anaesthesia Induced Hypotension
Not yet recruiting
Lumbar Erector Spinae Plane Block Versus PENG Block for Hip Fracture Surgery
Femur Neck Fracture, Hip Fractures
Active, not recruiting
Lumbar-Sacral Plexus Block vs Fascia Iliaca Block Plus Low-Dose Spinal Anesthesia for Femoral Neck Fracture Surgery
Femoral Neck Fractures, Nerve Block
Not yet recruiting
A Decision Support Tool for Common Surgical Fixations of Hip Fractures
Hip Fracture Surgeries, High Risk Population of Hip Fractures
Not yet recruitingPhase 4
Suzetrigine (Journavx) as Multimodal Therapy for Pain Management in Adults Undergoing Surgery for Hip Fracture
Hip Fractures (ICD-10 72.01-72.2), Post Operative Analgesia
Referral and contact
AzTrials does not enrol participants or take referrals. Contact the study team or a site listed below; they decide who can take part. This study is not recruiting at the moment.
The record lists no contact. Use the official record to reach the sponsor.
1 site in 1 country: see every site and its status.
Questions about this trial
What is this clinical trial studying?
A Phase 4 study testing Bupivacain and Nalbuphine in people with Hip Fracture Surgeries, run by Liaquat National Hospital & Medical College at 1 site in Pakistan.
The full registered description is in the About this study section and the official record.
Who may be eligible to take part?
The sponsor lists 1 inclusion and 1 exclusion criteria. Eligibility is decided by the study team after screening, so read the full criteria and contact a listed site.
Is this clinical trial currently recruiting?
The record says: under way, not looking for participants, as of the sponsor's last update on 29 May 2026. Status can change between updates, so confirm with the study contact before making plans.
Where is the study taking place?
The record lists 1 site in Pakistan. Whether a site is taking part right now should be confirmed with that site. See every site.
What are the possible benefits and risks?
They depend on the study and the treatment, and no study can promise a benefit. The study team explains the known risks during informed consent, before anyone joins; the record itself does not list them.
What does this phase mean?
Phase 4 studies take place after a treatment is approved, to learn more about its long-term benefits and risks in everyday use.
Not every study follows the same path, and some studies (observational studies, device studies) have no phase.
Are results available for this study?
This study is still under way. Results are not available in the source record yet.
How can a doctor refer a patient or contact the research team?
The record lists no contact. The official record names the sponsor, who can be asked directly. AzTrials does not enrol participants or take referrals.
What does the primary outcome measure?
Pain score(VAS score) after 15 minutes of either intervention before spinal anesthesia (time frame: 15 minutes). The study lists 2 primary outcomes in all. It is what the study was designed to measure, not a finding.
Where can I read the original study information?
Does a listing mean the treatment is approved or proven to work?
No. A listing means the study is registered. It does not show that the treatment is safe, works, or is approved by a regulator.
How often is this information updated?
AzTrials copies changed records from ClinicalTrials.gov every night and reloads the whole registry every week. The sponsor last updated this record on 29 May 2026.